Get the Stockscreener App
1.40
2.19%
0.03
180 Life Sciences Corp stock is traded at $1.40, with a volume of 57,271.
It is up +2.19% in the last 24 hours and down -18.60% over the past month.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
See More
Previous Close:
$1.37
Open:
$1.38
24h Volume:
57,271
Relative Volume:
0.14
Market Cap:
$4.38M
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
-0.2908
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-0.71%
1M Performance:
-18.60%
6M Performance:
-19.08%
1Y Performance:
-62.21%
1-Day Range:
$1.37
$1.41
1-Week Range:
$1.30
$1.5092
52-Week Range:
$1.16
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
1.40 | 4.38M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.34 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.18 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
667.51 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.46 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.28 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq
180 Life Sciences (NASDAQ:ATNF) Earns Sell (E+) Rating from Weiss Ratings - Defense World
Athena Bitcoin Global Announces Appointment of Omar Jimenez as Chief Financial Officer - ACCESS Newswire
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
180 Life Sciences to Raise $2.9M as It Shifts Focus to iGaming - GamblingNews.com
180 Life Sciences Corp. expands stock incentive plan - Investing.com India
180 Life Sciences Doubles Down on iGaming with $2.9M Fundraising Effort - Real Money Gambling News
180 Life Sciences Announces Key Proposals and Director Elections - TipRanks
US biotech firm announces $2.9m stock offering amid pivot to iGaming - NEXT.io
Stock offering fuels company's leap to iGaming - Silicon Valley Business Journal
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under NASDAQ Rules - Marketscreener.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Expands By 148.1% - Defense World
Stock market news: Siyata Mobile -90.00%, PainReform -29.18% among biggest losers during mid day trading - Business Upturn
Stock market today: Siyata Mobile -89.40%, Millennium Group International -27.94% among biggest losers in early trading - Business Upturn
180 Life Sciences announces $2.9 million securities offering - Investing.com
180 Life Sciences (ATNF) Raises $2.9M in Direct Offering, Pivots to Entertainment & iGaming - StockTitan
Alector (ALEC) Stock Dips Amid Mixed Analyst Ratings - GuruFocus.com
180 Life Sciences Corp. Announces Board Changes - Marketscreener.com
180 Life Sciences Corp. Announces Executive Changes - Marketscreener.com
180 Life Sciences Corp. announces CFO resignation - Investing.com India
180 Life Sciences CFO Omar Jimenez Resigns - TipRanks
180 Life Sciences Corp. announces CFO resignation By Investing.com - Investing.com UK
XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund - Yahoo Finance
Sai Life Sciences IPO listing date: Check objectives, subscription and other key details ahead of debut - Upstox
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - AccessWire
180 Life Sciences Regains Nasdaq Compliance, Advances Strategic Pivot into iGaming Tech - StockTitan
Pre-market Movers: PALI, KROS, AVGR, TRVI... - RTTNews
ChromaDex maintains Buy rating on recent agreement - Investing.com
180 Life Sciences Expands Board with Stephen Shoemaker - TipRanks
180 Life Sciences Taps Gaming Veteran Who Raised $2B for Strategic iGaming Pivot - StockTitan
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - AccessWire
United States shares higher at close of trade; Dow Jones Industrial Average up 0.79% - MSN
180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TURN180 Degree Capital Corp. Latest Stock News & Market Updates - StockTitan
180 Life Sciences Corp. Warrant (ATNFW) Quarterly 10-Q Report - Quartzy
ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com
Artelo Biosciences (ARTL) Shares Dive Amidst Biotech Sector Move - GuruFocus.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
IMAB Stock Plummets Amidst Broader Biotech Industry Decline - GuruFocus.com
ChromaDex stock soars to 52-week high, hits $4.69 - Investing.com
180 Life Sciences Expands into Online Gaming Sector - TipRanks
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - AccessWire
180 Life Sciences adds tech executive to board By Investing.com - Investing.com Canada
180 Life Sciences Corp. Sets Date for 2024 Annual Meeting By Investing.com - Investing.com South Africa
180 Life Sciences Corp. Sets Date for 2024 Annual Meeting - Investing.com India
180 Life Sciences adds tech executive to board - Investing.com India
180 Life Sciences Expands Board Amidst Strategic Growth - TipRanks
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):